Trial Outcomes & Findings for Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds (NCT NCT05234632)

NCT ID: NCT05234632

Last Updated: 2025-06-06

Results Overview

Delivery of nominal -80mmHg negative pressure over the treatment period was measured by download of the built-in data chip from the PICO 14 devices to collect NPWT delivery status. This data was summarized to provide the average negative pressure delivery overall and for both closed incisions and chronic/dehisced surgical wounds.

Recruitment status

TERMINATED

Target enrollment

45 participants

Primary outcome timeframe

Day 30

Results posted on

2025-06-06

Participant Flow

Overall, 45 participants were enrolled to the study at 6 sites. There was one (1) screen failure, leaving 44 subjects (25 closed incisions; 19 chronic wounds) receiving PICO 14 NPWT treatment forming the safety analysis set (SAF).

Participant milestones

Participant milestones
Measure
PICO 14 Closed Incisions
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Overall Study
STARTED
25
19
Overall Study
COMPLETED
20
13
Overall Study
NOT COMPLETED
5
6

Reasons for withdrawal

Reasons for withdrawal
Measure
PICO 14 Closed Incisions
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Overall Study
Participant Withdrawn: Non-Compliance
1
0
Overall Study
Withdrawal by Subject
2
0
Overall Study
Adverse Event
0
4
Overall Study
Physician Decision
1
1
Overall Study
Participant tested positive for COVID-19 and is in isolation
0
1
Overall Study
Withdrawn by participant upon experiencing Adverse Event.
1
0

Baseline Characteristics

Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PICO 14 Closed Incisions
n=25 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Total
n=44 Participants
Total of all reporting groups
Age, Continuous
71.6 years
STANDARD_DEVIATION 10.2 • n=5 Participants
71.3 years
STANDARD_DEVIATION 16.3 • n=7 Participants
71.5 years
STANDARD_DEVIATION 13.0 • n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
13 Participants
n=7 Participants
29 Participants
n=5 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
6 Participants
n=7 Participants
15 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Caucasian
25 Participants
n=5 Participants
15 Participants
n=7 Participants
40 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Black
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Race · Other
0 Participants
n=5 Participants
4 Participants
n=7 Participants
4 Participants
n=5 Participants
Region of Enrollment
United Kingdom
25 participants
n=5 Participants
16 participants
n=7 Participants
41 participants
n=5 Participants
Region of Enrollment
Germany
0 participants
n=5 Participants
3 participants
n=7 Participants
3 participants
n=5 Participants
Body Mass Index (BMI)
29.1 kg/m^2
STANDARD_DEVIATION 4.6 • n=5 Participants
30.0 kg/m^2
STANDARD_DEVIATION 9.8 • n=7 Participants
29.5 kg/m^2
STANDARD_DEVIATION 7.1 • n=5 Participants

PRIMARY outcome

Timeframe: Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.

Delivery of nominal -80mmHg negative pressure over the treatment period was measured by download of the built-in data chip from the PICO 14 devices to collect NPWT delivery status. This data was summarized to provide the average negative pressure delivery overall and for both closed incisions and chronic/dehisced surgical wounds.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=18 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
n=13 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
n=31 Participants
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Delivery of Nominal -80mmHg Negative Pressure
-77.2 millimeters of mercury (mmHg)
Standard Deviation 7.7
-74.7 millimeters of mercury (mmHg)
Standard Deviation 11.4
-76.2 millimeters of mercury (mmHg)
Standard Deviation 9.3

PRIMARY outcome

Timeframe: Up to 30 Days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.

Exudate management was measured by the number of participants with no exudate leaks identified by the clinician at any point over the treatment period, up to 30 days.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
n=13 Participants
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
n=33 Participants
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Exudate Management: Occurrence of No Exudate Leaks
13 Participants
8 Participants
21 Participants

SECONDARY outcome

Timeframe: Day 14 and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated.

The Patient and Observer Scar Assessment Scale (POSAS) is a comprehensive scale that is designed for the evaluation of all types of scars by professionals and patients. The POSAS consists of two parts: a Patient Scale and an Observer Scale. Both scales contain six items that are scored numerically and make up a 'Total Score' of the Patient and Observer Scale. Each item of both scales has a 10-point score, with 10 indicating the worst imaginable scar or sensation. The lowest score is '1', and corresponds to the situation of normal skin (normal pigmentation, no itching etc.), and goes up to the worst imaginable. The Total Score is provided for both the Patient Scale and Observer Scale at Day 14 \& Day 30. The Total Score for both scales was calculated by summing up the scores of each of the six items. The Total Score ranged from 6 to 60 with a lower score indicating a better outcome.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 14: Patient Scale Total Score
18.9 score on a scale
Standard Deviation 11.9
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 14: Observer Scale Total Score
16.3 score on a scale
Standard Deviation 9
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 30: Patient Scale Total Score
19.5 score on a scale
Standard Deviation 10.6
Scar Quality Measured by The Patient and Observer Scar Assessment Scale (POSAS): Closed Incision Only
Day 30: Observer Scale Total Score
13.7 score on a scale
Standard Deviation 7.4

SECONDARY outcome

Timeframe: Day 7, Day 14, and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated. The FAS population for this outcome measure includes only participants with Closed Incisions identified as not healed (i.e., not fully closed/epithelialized).

Incidence of Surgical Site Infections (SSI) as defined by The Centers for Disease Control and Prevention (CDC) criteria, for any incision that had not healed by the given assessment at Day 7, Day 14, and Day 30. The number of participants with an incision that is clinically infected were categorized as either 'Yes' or 'No' (e.g., Is Incision Clinically Infected: Yes or No).

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 7: Is Incision Clinically Infected · Yes
0 Participants
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 7: Is Incision Clinically Infected · No
8 Participants
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 14: Is Incision Clinically Infected · Yes
2 Participants
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 14: Is Incision Clinically Infected · No
0 Participants
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 30: Is Incision Clinically Infected · Yes
0 Participants
Number of Participants With Surgical Site Infections (SSC): Closed Incisions Only
Day 30: Is Incision Clinically Infected · No
2 Participants

SECONDARY outcome

Timeframe: Day 7, Day 14, and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated. The FAS population for this outcome measure includes only participants with Closed Incisions identified as not healed (i.e., not fully closed/epithelialized).

Incidence of Surgical Site Complication (SSC) for any incision that had not healed by the given assessment at Day 7, Day 14, and Day 30. The number of participants where dehiscence of incision occurred, were categorized as either 'Yes' or 'No' (e.g., Incision dehisced: Yes or No).

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 7: Incision Dehisced · Yes
0 Participants
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 7: Incision Dehisced · No
8 Participants
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 14: Incision Dehisced · Yes
1 Participants
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 14: Incision Dehisced · No
1 Participants
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 30: Incision Dehisced · Yes
1 Participants
Number of Participants With Surgical Site Complication (SSC): Closed Incisions Only
Day 30: Incision Dehisced · No
1 Participants

SECONDARY outcome

Timeframe: Day 7, Day 14, and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

The clinician assessed the condition of the surrounding skin of closed incisions at Day 7, Day 14, and Day 30. The condition of skin was categorized as the number of participants where any of the following characteristics apply: * Healthy * Fragile * Inflamed * Erythematous * Oedematous * Eczematous * Macerated * Bruising * Dry and flaky * Other

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=22 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Other
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Healthy
20 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Healthy
18 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Fragile
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Inflamed
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Erythematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Oedematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Macerated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Bruising
11 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Dry and flaky
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 7: Other
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Healthy
15 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Fragile
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Inflamed
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Erythematous
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Oedematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Macerated
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Bruising
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 14: Dry and flaky
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Fragile
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Inflamed
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Erythematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Oedematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Macerated
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Bruising
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Dry and flaky
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at 7, 14 and 30 Days: Closed Incisions Only
Day 30: Other
0 Participants

SECONDARY outcome

Timeframe: Up to 14 Days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Level of pain on dressing application, during wear and at dressing removal assessed by Visual Analog Score (VAS) scale over the 14 day treatment period. The VAS scale ranges from 0-10 with 0 being no pain and 10 being extreme pain.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=47 Dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: Dressing Application
0.5 score on a scale
Standard Deviation 1.3
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: During Wear
2.5 score on a scale
Standard Deviation 2.5
Level of Pain - Visual Analog Score (VAS): Closed Incisions Only
Level of Pain: Dressing Removal
1.3 score on a scale
Standard Deviation 1.9

SECONDARY outcome

Timeframe: Day 7, Day 14, and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Patient satisfaction in performance at Day 7, Day 14, and Day 30 (follow-up) measured by response of 'Yes' or 'No' to the following: * Overall performance * Comfort during wear * Noise level * Discreetness * Portability

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Overall performance · Yes
20 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Overall performance · No
0 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Comfort during wear · Yes
19 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Comfort during wear · No
1 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Noise level · Yes
18 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Noise level · No
2 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Discreetness · Yes
20 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Discreetness · No
0 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Portability · Yes
18 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 7: Portability · No
2 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Overall performance · Yes
18 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Overall performance · No
1 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Comfort during wear · Yes
16 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Comfort during wear · No
3 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Noise level · Yes
16 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Noise level · No
3 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Discreetness · Yes
17 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Discreetness · No
2 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Portability · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 14: Portability · No
6 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Overall performance · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Overall performance · No
0 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Comfort during wear · Yes
11 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Comfort during wear · No
2 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Noise level · Yes
10 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Noise level · No
3 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Discreetness · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Discreetness · No
0 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Portability · Yes
12 Participants
Patient Satisfaction During Wear - Performance: Closed Incisions Only
Day 30: Portability · No
1 Participants

SECONDARY outcome

Timeframe: Day 7, Day 14, and Day 30

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Patient satisfaction during wear in interference with daily living at Day 7, Day 14, and Day 30 (follow-up) measured by response of 'Yes' or 'No' to the following: * Showering * Sleeping * Socializing * Working

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=20 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Showering · Yes
8 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Showering · No
3 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Sleeping · Yes
18 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Sleeping · No
2 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Socializing · Yes
13 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Socializing · No
0 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Working · Yes
2 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 7: Working · No
1 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Showering · Yes
10 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Showering · No
3 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Sleeping · Yes
16 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Sleeping · No
3 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Socializing · Yes
16 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Socializing · No
0 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Working · Yes
2 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 14: Working · No
3 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Showering · Yes
5 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Showering · No
2 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Sleeping · Yes
11 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Sleeping · No
2 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Socializing · Yes
11 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Socializing · No
1 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Working · Yes
4 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Closed Incisions Only
Day 30: Working · No
1 Participants

SECONDARY outcome

Timeframe: Up to 14 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Ease of application and removal of the PICO 14 dressing for Closed Incisions determined by overall count of dressings applied/removed based on responses to the questions "Was it easy to apply the dressing" and "Was it easy to remove the dressing" as either 'Yes' or 'No'.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=48 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Ease of Application and Removal: Closed Incisions Only
Was it easy to apply the dressing · Yes
48 dressings
Ease of Application and Removal: Closed Incisions Only
Was it easy to apply the dressing · No
0 dressings
Ease of Application and Removal: Closed Incisions Only
Was it easy to remove the dressing · Yes
46 dressings
Ease of Application and Removal: Closed Incisions Only
Was it easy to remove the dressing · No
2 dressings

SECONDARY outcome

Timeframe: Up to 14 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Overall dressing wear time in days for Closed Incisions only.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=51 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Dressing Wear Time: Closed Incisions Only
5.7 days
Standard Deviation 2.1

SECONDARY outcome

Timeframe: Up to 14 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Dressing conformability to the closed incision wound measured by the number of responses to the question "Was the dressing conformable on the incision/wound?" as either 'Yes' or 'No'.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=48 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Dressing Conformability: Closed Incisions Only
Yes
48 dressings
Dressing Conformability: Closed Incisions Only
No
0 dressings

SECONDARY outcome

Timeframe: Up to 14 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Dressing change frequency summarized as the number of dressings used per participants for Closed Incisions.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=22 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Number of Dressings Used: Closed Incisions Only
2.2 dressings per participant
Standard Deviation 1.0

SECONDARY outcome

Timeframe: Up to 14 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Reason for dressing change for Closed Incisions only. Count of occurrences by dressing were categorized as 'Yes' or 'No': * Routine dressing change * Inadequate exudate management * Pain/discomfort * Dressing damaged * Dressing fell off * Patient removed dressing * Adverse Event * Surgical procedure * Safety alarm * Dressing components not in place * No vacuum * other

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=51 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Reason for Dressing Change: Closed Incisions Only
Surgical procedure · No
51 dressings
Reason for Dressing Change: Closed Incisions Only
Routine dressing change · Yes
37 dressings
Reason for Dressing Change: Closed Incisions Only
Routine dressing change · No
14 dressings
Reason for Dressing Change: Closed Incisions Only
Inadequate exudate management · Yes
5 dressings
Reason for Dressing Change: Closed Incisions Only
Inadequate exudate management · No
46 dressings
Reason for Dressing Change: Closed Incisions Only
Pain/discomfort · Yes
0 dressings
Reason for Dressing Change: Closed Incisions Only
Pain/discomfort · No
51 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing damaged · Yes
0 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing damaged · No
51 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing fell off · Yes
0 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing fell off · No
51 dressings
Reason for Dressing Change: Closed Incisions Only
Patient removed dressing · Yes
1 dressings
Reason for Dressing Change: Closed Incisions Only
Patient removed dressing · No
50 dressings
Reason for Dressing Change: Closed Incisions Only
Adverse Event · Yes
4 dressings
Reason for Dressing Change: Closed Incisions Only
Adverse Event · No
47 dressings
Reason for Dressing Change: Closed Incisions Only
Surgical procedure · Yes
0 dressings
Reason for Dressing Change: Closed Incisions Only
Safety alarm · Yes
1 dressings
Reason for Dressing Change: Closed Incisions Only
Safety alarm · No
50 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing components not in place · Yes
1 dressings
Reason for Dressing Change: Closed Incisions Only
Dressing components not in place · No
50 dressings
Reason for Dressing Change: Closed Incisions Only
No vacuum · Yes
2 dressings
Reason for Dressing Change: Closed Incisions Only
No vacuum · No
49 dressings
Reason for Dressing Change: Closed Incisions Only
Other · Yes
3 dressings
Reason for Dressing Change: Closed Incisions Only
Other · No
48 dressings

SECONDARY outcome

Timeframe: Day 14

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Closed Incisions only.

Acceptability of the device determined from the clinician's response (Yes/No) at discontinuation of therapy by participant (i.e., Day 14) to the question: Overall are you satisfied with the performance of the PICO 14 system (pump and PICO 14 dressing)?

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=19 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Closed Incision Only
Yes
19 Participants
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Closed Incision Only
No
0 Participants

SECONDARY outcome

Timeframe: Day 0, Day 7, Day 14, Day 21, and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Count of participants with presence of infection as determined by the clinical signs and symptoms at Day 0, Day 7, Day 14, Day 21, and Day 28 for Chronic and Dehisced Surgical Wounds (i.e., clinically infected: 'Yes' or 'No').

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 0: Clinically infected · Yes
0 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 0: Clinically infected · No
16 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 7: Clinically infected · Yes
0 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 7: Clinically infected · No
16 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 14: Clinically infected · Yes
0 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 14: Clinically infected · No
15 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 21: Clinically infected · Yes
0 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 21: Clinically infected · No
14 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 28: Clinically infected · Yes
0 Participants
Number of Participants With Clinical Infection: Chronic and Dehisced Surgical Wounds Only
Day 28: Clinically infected · No
13 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by size measured by the length and width in centimeters at screening and Day 28 for Chronic and Dehisced Surgical Wounds only.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Screening: Length
5.9 centimeters (cm)
Standard Deviation 5.2
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Day 28: Length
3.1 centimeters (cm)
Standard Deviation 2.2
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Screening: Width
4.5 centimeters (cm)
Standard Deviation 2.9
Appearance of the Wound by Size: Chronic and Dehisced Surgical Wounds Only
Day 28: Width
3.1 centimeters (cm)
Standard Deviation 2.4

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by depth measured in millimeters at screening and Day 28 for Chronic and Dehisced Surgical Wounds only.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Depth: Chronic and Dehisced Surgical Wounds Only
Screening: Depth
10.6 millimeters (mm)
Standard Deviation 11.1
Appearance of the Wound by Depth: Chronic and Dehisced Surgical Wounds Only
Day 28: Depth
3.2 millimeters (mm)
Standard Deviation 5.7

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by number of participants with the presence of necrotic tissue (Yes/No) at screening and Day 28 for Chronic and Dehisced Surgical Wounds.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Necrotic Tissue · Yes
3 Participants
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Necrotic Tissue · Yes
8 Participants
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Necrotic Tissue · No
8 Participants
Appearance of the Wound by Presence of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Necrotic Tissue · No
10 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with presence of necrotic tissue only.

Appearance of the wound by amount of necrotic tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * \<25% of wound bed covered * 25% to 50% of wound covered * 50% to \< 75% of wound covered * 75% to 100% of wound covered

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · <25% of wound bed covered
5 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 25% to 50% of wound covered
2 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 50% to < 75% of wound covered
1 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Screening: Necrotic Tissue Amount · 75% to 100% of wound covered
0 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · <25% of wound bed covered
2 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 25% to 50% of wound covered
0 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 50% to < 75% of wound covered
1 Participants
Appearance of the Wound by Necrotic Tissue Amount: Chronic and Dehisced Surgical Wounds Only
Day 28: Necrotic Tissue Amount · 75% to 100% of wound covered
0 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with presence of necrotic tissue only.

Appearance of the wound by type of necrotic tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * White/grey non-viable tissue * Non-adherent, yellow slough * Loosely adherent, yellow slough * Adherent, soft, black eschar * Firmly adherent, hard/black eschar

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=8 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · White/grey non-viable tissue
0 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Adherent, soft, black eschar
0 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Non-adherent, yellow slough
3 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Loosely adherent, yellow slough
5 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Type of Necrotic Tissue · Firmly adherent, hard/black eschar
0 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · White/grey non-viable tissue
0 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Non-adherent, yellow slough
1 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Loosely adherent, yellow slough
2 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Adherent, soft, black eschar
0 Participants
Appearance of the Wound by Type of Necrotic Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Type of Necrotic Tissue · Firmly adherent, hard/black eschar
0 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by granulation tissue at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * Skin intact or partial thickness wound * Bright, beefy red; 75% to 100% of wound filled \&/or tissue overgrowth * Bright, beefy red; \< 75% \& \>25% of wound filled * Pink, \&/or dull, dusky red \&/or fills \<25% of wound * No granulation tissue present

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Skin intact or partial thickness wound
0 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Bright, beefy red; 75% to 100% of wound filled &/or tissue overgrowth
7 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Bright, beefy red; < 75% & >25% of wound filled
6 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · Pink, &/or dull, dusky red &/or fills <25% of wound
3 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Screening: Granulation Tissue · No granulation tissue present
0 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Skin intact or partial thickness wound
1 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Bright, beefy red; 75% to 100% of wound filled &/or tissue overgrowth
5 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Bright, beefy red; < 75% & >25% of wound filled
6 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · Pink, &/or dull, dusky red &/or fills <25% of wound
1 Participants
Appearance of the Wound by Granulation Tissue: Chronic and Dehisced Surgical Wounds Only
Day 28: Granulation Tissue · No granulation tissue present
0 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by epithelialization at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as number of participants with: * 100% wound covered, surface intact * 75% to \< 100% wound covered \&/or epithelial tissue extends to \> 0.5 cm into wound bed * 50% to \< 75% wound covered \&/or epithelial tissue extends to \< 0.5 cm into wound bed * 25% to \< 50% wound covered * \< 25% wound covered

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 100% wound covered, surface intact
0 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 75% to < 100% wound covered &/or epithelial tissue extends to > 0.5 cm into wound bed
0 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 50% to < 75% wound covered &/or epithelial tissue extends to < 0.5 cm into wound bed
0 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · 25% to < 50% wound covered
0 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Screening: Epithelialization · < 25% wound covered
16 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 100% wound covered, surface intact
0 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 75% to < 100% wound covered &/or epithelial tissue extends to > 0.5 cm into wound bed
1 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 50% to < 75% wound covered &/or epithelial tissue extends to < 0.5 cm into wound bed
1 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · 25% to < 50% wound covered
2 Participants
Appearance of the Wound by Epithelialization: Chronic and Dehisced Surgical Wounds Only
Day 28: Epithelialization · < 25% wound covered
9 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Appearance of the wound by number of participants with presence of exudate (Yes/No) at screening and Day 28 for Chronic and Dehisced Surgical Wounds.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Exudate · Yes
15 Participants
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Presence of Exudate · No
1 Participants
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Exudate · Yes
12 Participants
Appearance of the Wound by Presence of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Presence of Exudate · No
1 Participants

SECONDARY outcome

Timeframe: Screening and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds with exudate present only.

Appearance of the wound by number of participants level of exudate at screening and Day 28 for Chronic and Dehisced Surgical Wounds categorized as: * Light * Moderate * Heavy

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Moderate
5 Participants
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Light
2 Participants
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Moderate
12 Participants
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Screening: Level of Exudate · Heavy
1 Participants
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Light
6 Participants
Appearance of the Wound by Level of Exudate: Chronic and Dehisced Surgical Wounds Only
Day 28: Level of Exudate · Heavy
1 Participants

SECONDARY outcome

Timeframe: Day 0, Day 7, Day 14, Day 21, and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

The clinician assessed the condition of the surrounding skin of Chronic and Dehisced Surgical Wounds at Day 0, Day 7, Day 14, Day 21, and Day 28. The condition of skin was categorized as the number of participants where any of the following characteristics apply: * Normal * Erythematous * Oedematous * Eczematous * Excoriated * Macerated * Indurated * Other

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Normal
7 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Erythematous
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Oedematous
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Excoriated
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Macerated
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Indurated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 0 : Other
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Normal
6 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Erythematous
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Oedematous
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Excoriated
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Macerated
5 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Indurated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 7 : Other
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Normal
5 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Erythematous
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Oedematous
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Excoriated
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Macerated
5 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Indurated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 14 : Other
3 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Normal
5 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Erythematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Oedematous
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Eczematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Excoriated
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Macerated
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Indurated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 21 : Other
5 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Normal
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Erythematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Oedematous
1 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Eczematous
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Excoriated
2 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Macerated
4 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Indurated
0 Participants
Condition of Peri-Wound Skin Assessed Through Visual Inspection at Day 0, Day 7, Day 14, Day 21, and Day 28 Days: Chronic and Dehisced Surgical Wounds Only
Day 28 : Other
3 Participants

SECONDARY outcome

Timeframe: Day 7, Day 14, Day 21, and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

The reference wound area captured at each study visit. Percentage change in area calculated and summarized using a Wilcoxon Signed Rank test from baseline to all post-baseline study visits at Day 7, Day 14, Day 21, and Day 28.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 7
17.5 percent change in wound area
Standard Deviation 24.7
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 14
18.6 percent change in wound area
Standard Deviation 31.0
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 21
42.2 percent change in wound area
Standard Deviation 22.7
Percentage Change in Area of Wound: Chronic and Dehisced Surgical Wounds Only
Day 28
50.5 percent change in wound area
Standard Deviation 24.0

SECONDARY outcome

Timeframe: Day 7, Day 14, Day 21, and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

The reference wound volume captured at each study visit. Percentage change in volume calculated and summarized using a Wilcoxon Signed Rank test from baseline to all post-baseline study visits at Day 7, Day 14, Day 21, and Day 28.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 7
41.8 percent change in wound volume
Standard Deviation 30.3
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 14
52.3 percent change in wound volume
Standard Deviation 32.8
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 21
72.7 percent change in wound volume
Standard Deviation 30.8
Percentage Change in Volume of Wound: Chronic and Dehisced Surgical Wounds Only
Day 28
79.3 percent change in wound volume
Standard Deviation 24.7

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Level of pain on application, during wear and at dressing removal assessed by Visual Analog Score (VAS) scale over the 28 day treatment period. The VAS scale ranges from 0-10 with 0 being no pain and 10 being extreme pain.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=99 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: Dressing Application
0.4 score on a scale
Standard Deviation 1.4
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: During Wear
1.1 score on a scale
Standard Deviation 2.1
Level of Pain - Visual Analog Score (VAS): Chronic and Dehisced Surgical Wounds Only
Level of Pain: Dressing Removal
1.5 score on a scale
Standard Deviation 2.4

SECONDARY outcome

Timeframe: Day 14 and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Patient satisfaction in performance at Day 14 and Day 28 measured by response of 'Yes' or 'No' to the following: * Overall performance * Comfort during wear * Noise level * Discreetness * Portability

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Overall performance · Yes
15 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Overall performance · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Comfort during wear · Yes
15 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Comfort during wear · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Noise level · Yes
15 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Noise level · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Discreetness · Yes
15 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Discreetness · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Portability · Yes
15 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 14: Portability · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Overall performance · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Overall performance · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Comfort during wear · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Comfort during wear · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Noise level · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Noise level · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Discreetness · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Discreetness · No
0 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Portability · Yes
13 Participants
Patient Satisfaction During Wear - Performance: Chronic and Dehisced Surgical Wounds Only
Day 28: Portability · No
0 Participants

SECONDARY outcome

Timeframe: Day 14 and Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Patient satisfaction during wear in interference with daily living at Day 14 and Day 28 measured by response of 'Yes' or 'No' to the following: * Showering * Sleeping * Socializing * Working

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=15 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Showering · Yes
8 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Showering · No
6 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Sleeping · Yes
15 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Sleeping · No
0 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Socializing · Yes
14 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Socializing · No
1 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Working · Yes
7 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 14: Working · No
7 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Showering · Yes
8 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Showering · No
5 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Sleeping · Yes
13 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Sleeping · No
0 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Socializing · Yes
12 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Socializing · No
1 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Working · Yes
8 Participants
Patient Satisfaction During Wear - Interference With Daily Living: Chronic and Dehisced Surgical Wounds Only
Day 28: Working · No
5 Participants

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Ease of application and removal of the PICO 14 dressing for Chronic and Dehisced Surgical Wounds determined by overall count of dressings applied/removed based on responses to the questions "Was it easy to apply the dressing" and "Was it easy to remove the dressing" as either 'Yes' or 'No'.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=113 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to apply the dressing · Yes
112 dressings
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to apply the dressing · No
1 dressings
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to remove the dressing · Yes
105 dressings
Ease of Application and Removal: Chronic and Dehisced Surgical Wounds Only
Was it easy to remove the dressing · No
4 dressings

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Dressing wear time in days summarized for Chronic and Dehisced Surgical Wounds over the treatment period up to 28 days.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=114 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Dressing Wear Time: Chronic and Dehisced Surgical Wounds Only
3.6 days
Standard Deviation 2.0

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Dressing conformability to the wound measured by the number of responses to the question "Was the dressing conformable on the incision/wound?" as either 'Yes' or 'No'.

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=112 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Dressing Conformability: Chronic and Dehisced Surgical Wounds Only
Yes
112 dressings
Dressing Conformability: Chronic and Dehisced Surgical Wounds Only
No
0 dressings

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Dressing change frequency summarized as the number of dressings used per participant for Chronic and Dehisced Surgical Wounds

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=16 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Number of Dressings Used: Chronic and Dehisced Surgical Wounds Only
7.1 dressings per participant
Standard Deviation 3.3

SECONDARY outcome

Timeframe: Up to 28 days

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Reason for dressing change for Chronic and Dehisced Surgical Wounds only. Count of occurrences by dressing were categorized as 'Yes' or 'No': * Routine dressing change * Inadequate exudate management * Pain/discomfort * Dressing damaged * Dressing fell off * Patient removed dressing * Adverse Event * Surgical procedure * Safety alarm * Dressing components not in place * No vacuum * other

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=114 dressings
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Inadequate exudate management · Yes
8 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Inadequate exudate management · No
106 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing damaged · Yes
0 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing damaged · No
114 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing fell off · Yes
3 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing fell off · No
111 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Patient removed dressing · Yes
0 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Patient removed dressing · No
114 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Adverse Event · Yes
2 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Adverse Event · No
112 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Surgical procedure · Yes
0 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Surgical procedure · No
114 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Safety alarm · Yes
2 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Safety alarm · No
112 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing components not in place · Yes
0 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Dressing components not in place · No
114 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
No vacuum · Yes
3 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
No vacuum · No
111 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Other · Yes
17 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Other · No
97 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Routine dressing change · Yes
84 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Routine dressing change · No
30 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Pain/discomfort · Yes
0 dressings
Reason for Dressing Change: Chronic and Dehisced Surgical Wounds Only
Pain/discomfort · No
114 dressings

SECONDARY outcome

Timeframe: Day 28

Population: Full Analysis Set (FAS) population included all participants recruited into the study that attended at least one post-baseline assessment with available data at the time frame indicated for Chronic and Dehisced Surgical Wounds only.

Acceptability of the device determined from the clinician's response (Yes/No) at discontinuation of therapy by participant (i.e., Day 28) to the question: Overall are you satisfied with the performance of the PICO 14 system (pump and PICO 14 dressing)?

Outcome measures

Outcome measures
Measure
PICO 14 Closed Incisions
n=13 Participants
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Overall (Closed Incisions & Chronic/Dehisced Wounds)
Any wound treated with PICO 14. For closed Surgical incisions this will be for 14 days post surgery and with a 30 day follow up. For chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Chronic and Dehisced Surgical Wounds Only
Yes
13 Participants
Clinician Acceptability of PICO 14 at Discontinuation of Therapy: Chronic and Dehisced Surgical Wounds Only
No
0 Participants

Adverse Events

PICO 14 Closed Incisions

Serious events: 1 serious events
Other events: 21 other events
Deaths: 0 deaths

PICO 14 Chronic/Dehisced Surgical Wounds

Serious events: 3 serious events
Other events: 11 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
PICO 14 Closed Incisions
n=25 participants at risk
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 participants at risk
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
Blood and lymphatic system disorders
ANEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Respiratory, thoracic and mediastinal disorders
ADMITTED TO HOSPITAL WITH A CHEST INFECTION.
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PATIENTS GENERAL HEALTH HAS QUICKLY DECLINED AND IS NOW AT END OF LIFE
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PATIENT HOSPITALISED WITH CHEST PAIN
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Infections and infestations
WOUND INFECTION
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.

Other adverse events

Other adverse events
Measure
PICO 14 Closed Incisions
n=25 participants at risk
Any Closed incision treated with PICO 14, for closed Surgical incisions this will be for 14 days post-surgery and with a 30 day follow up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
PICO 14 Chronic/Dehisced Surgical Wounds
n=19 participants at risk
Any Chronic/Dehisced Surgical wound treated with PICO 14, for chronic and dehisced wounds this will be for up to 28 days therapy and no follow-up. PICO 14 single-use Negative Pressure Wound Therapy System: The PICO14 device delivers negative pressure across the wound bed or closed incision and surrounding area, and exudate is managed by the dressing through a combination of absorption and evaporation of moisture through the outer film.
General disorders
ABDOMINAL DISCOMFORT
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
ABDOMINAL PAIN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
ACUTE KIDNEY INJURY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
ANAEMIA POST SURGERY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
BLISTER ON RIGHT EDGE OF ADHESIVE STRIP
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
BLISTER TO BELLY BUTTON
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Vascular disorders
BLOOD STAINED SPUTUM
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
BP 106/47- HYPOTENSION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Cardiac disorders
BRADYCARDIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Respiratory, thoracic and mediastinal disorders
CHEST INFECTION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
CONGESTIVE DERMATITIS OF THE LOWER LEGS
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
CONSTIPATION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
DIARRHOEA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
DISTENDED ABDOMEN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
DRAIN SITE OOZING PUS AND RED
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
DRESSING STUCK TO THE WOUND AND CAUSED SOME EXCORIATION TO THE SURROUNDING SKIN
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
DROWSINESS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
ELEVATED INFLAMMATORY MARKERS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
ELEVATED WHITE BLOOD CELL COUNT POST-OPERATIVELY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
EXCORIATION TO SURROUNDING SKIN TO WOUND
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Vascular disorders
EXTENSIVE BRUISING TO OPERATED LEG
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
FAINT DAY 9 POST-OPERATIVELY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Injury, poisoning and procedural complications
FALL AT HOME- HIT HEAD
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Psychiatric disorders
FEELING GENERALLY UNWELL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
FEELING ROUGH
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
FRANK RECTAL BLEED
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Vascular disorders
HAEMATOMA AT WOUND SITE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
HAEMATURIA ON CATHETER REMOVAL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
HB 97
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
HEADACHES
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
HYPERGLYCAEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
HYPOGLYCEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
HYPOKALAEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
HYPOTENSION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
ILEOSTOMY LEAK INTO WOUND DRESSING
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
ILEUS
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Vascular disorders
INFECTED HAEMATOMA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
LEFT ELBOW PAIN. NUMBNESS TI RING & LITTLE FINGER
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
LOOSE BOWELS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
LOOSE STOOL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
LOOSE STOOL INCONTINENCE
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
LOW EGFR
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
LOW MAGNESIUM
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
LOW PHOSPHATE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
LOW POST-OPERATIVE SODIUM
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
LOW POTASSIUM
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
LOW SODIUM LEVEL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
LOW TEMPERATURE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
MACERATED WOUND EDGES
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
MELENA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
MIGRAINE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Musculoskeletal and connective tissue disorders
MILD CRAMPS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
MILD PAIN
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Immune system disorders
MONOCYTES: 0.9 HB: 102 WBC: 14.7 NEUTROPHILS: 11.7 CREATINE: 91 E-GFR/1.73M*2 50
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
NAUSEA
44.0%
11/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Respiratory, thoracic and mediastinal disorders
NONE PRODUCTIVE COUGH
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
OEDEMA- ANKLES
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
ON ARRIVAL WAS FOUND TO HAVE 2 X MOISTURE LESIONS TO SKIN
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
OOZING DRAIN WOUND SITE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
PAIN
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN AROUND WOUND SITE AFTER REMOVAL OF CLIPS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
PAIN CENTRAL ABDOMEN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN ON REMOVAL OF DRESSING
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Injury, poisoning and procedural complications
PAIN OPERATED SITE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN OPERATIVE SITE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN RIGHT SIDE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN VAS 6-8 IN OPERATED KNEE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Injury, poisoning and procedural complications
PAINFUL FOOT WHEN TWISTED ANKLE DURING A FALL
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Psychiatric disorders
PANIC ATTACKS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PARTICIPANT FINDING PICO14 DRESSING UNCOMFOTABLE, DISTURBING SLEEP
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
PAIN FROM COCCYX NOT WOUND SITE AS ADHESIVE STRIPS TOUCH COCCYX (PAIN IN COCCYX FROM PREVIOUS FALL)
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
PASSED FRESH BLOOD PER RECTUM
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
PATIENT DESCRIBES INTERMITTENT COOLING SENSATION ON FOOT OF OPERATED LEG
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Infections and infestations
PATIENT HAD COVID
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Respiratory, thoracic and mediastinal disorders
PATIENT PRESENTED AND TREATED FOR ONGOING EXACERBATED COPD SYMPTOMS & SUSPECTED CHEST INFECTION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
POOR URINE OUTPUT
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
POST-OPERATIVE ANAEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
POST-OPERATIVE ITCH
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
POSTURAL DROP HYPOTENSION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Injury, poisoning and procedural complications
PRESSURE DAMAGE TO THE DORSAL CREASE FROM STOCKING MOVEMENT AND CREASING OVER AREA
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Endocrine disorders
RAISED BLOOD SUGAR 9.6
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
RAISED C-REACTIVE PROTEIN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
RAISED CREATININE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
RAISED POST-OPERATIVE WHITE BLOOD CELLS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
RAISED RED BLOOD COUNT
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Immune system disorders
RAISED WHITE BLOOD COUNT
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
RECTAL BLEED
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
REDDEN AREA LEFT HEEL DUE TO PRESSURE, SKIN IS NOT BROKEN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Respiratory, thoracic and mediastinal disorders
REDUCED O2 SATURATIONS
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
SEVERE ITCHING ON SURGICAL SITE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
SKIN IRRITATION UNDER THE BANDAGE
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
SKIN RASH FORMED POST-OP, CLUSTERED IN DENSE LINES & AREAS OF SKIN ACROSS RIGHT-SID CHEST & SHOULDER
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
SLIGHT POST-OPERATIVE ANAEMIA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
SLUGGISH BOWEL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
SMALL BOWEL LOOP OBSTRUCTION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
SMALL BRUISING/DEEP TISSUE INJURY TO LEFT EDGE OF WOUND
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
SORE NOSE DUE TO NASOJEJUNAL AND NASOGASTRIC TUBE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
SUPERFICIAL WOUND DEHISCENE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
General disorders
SWELLING LOWER LEG
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Cardiac disorders
TACHYCARDIA
12.0%
3/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Skin and subcutaneous tissue disorders
TRAUMA TO WOUND BED ON REMOVAL OF DRESSING
0.00%
0/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
5.3%
1/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
TYPE 7 STOOL- DIARRHEA
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
URINARY RETENTION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
URINARY TRACT INFECTION
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Renal and urinary disorders
URINE CONCENTRATED
8.0%
2/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
VACANT EPISODE
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
VASOVAGAL
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Nervous system disorders
VERY DIZZY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
VOMITING
20.0%
5/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
VOMITTED GREEN FLUID
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Blood and lymphatic system disorders
WHITE CELL COUNT ELEVATED POST-OPERATIVELY
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
WIND LIKE UPPER ABDOMINAL PAIN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Gastrointestinal disorders
WIND PAIN
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
Injury, poisoning and procedural complications
WOUND INFECTION
4.0%
1/25 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.
0.00%
0/19 • Adverse events for closed incisions collected 14 days post-surgery with a further 16 days follow-up period, up to 30 days from initial application of treatment. Adverse events for chronic wounds and dehisced surgical wounds were collected up to 28 days during the therapy period with no follow up.

Additional Information

Dr Rochelle O'Hara

Smith & Nephew, Inc.

Phone: +44 1923 477218

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60